Biomarkers: Interleukin-17
Biomarkers: Interleukin-17
https://www.ijppp.org/files/ijppp0102911.pdf
Remarks:
1- The mean of serum level of IL-17 in the MS and NMO subjects was significantly higher than healthy subjects.
2 - The mean of serum level of IL-17 in the MS was significantly higher than NMO
- lyndacarol
- Family Elder
- Posts: 3392
- Joined: Thu Dec 22, 2005 3:00 pm
- Contact:
Re: Biomarkers: Interleukin-17
Re: Biomarkers: Interleukin-17
Re: Biomarkers: Interleukin-17
Sorry. I thought it was working worldwide. Maybe the URL works only from my university. Here are the paper data and the abstract:lyndacarol wrote: ↑Mon Jan 13, 2020 12:18 pmPlease confirm that the URL is correct and give us the title to the paper where these remarks were found.
Fereshte Ashtari, Reyhanehsadat Madanian, Vahid Shaygannejad, Sayyed Hamid Zarkesh, Keyvan Ghadimi
Serum levels of IL-6 and IL-17 in multiple sclerosis, neuromyelitis optica patients and healthy subjects
Int J Physiol Pathophysiol Pharmacol 2019;11(6):267-273
www.ijppp.org /ISSN:1944-8171/IJPPP0102911
Abstract:
Background:
Studies reported that evaluating the interleukin serum level of MS and NMO patients is help-ful for differentiating these two diseases from each other. This study aimed to compare the level of IL-6 and IL-17 in MS and NMO patients and healthy subjects.
Methods:
This study is a case control study that evaluated the serum level of IL-6 and IL-17 in MS and NMO patients in comparison to controls in patients who referred to Kashani hospital clinics. The level of serum IL-6 and IL-17 were measured by ELISA test in all patients. Participants were divided in to three groups include MS patients, NMO patients and controls and the level of IL-6 and IL-17 were compared in this three groups.
Results:
Mean of serum level of IL-6 in the NMO group was significantly lower than MS and healthy subject (P=0.02 for NMO and MS, P=0.001 for NMO and healthy subjects) but there was no significant difference between MS and healthy subjects (P=0.09). The mean of serum level of IL-17 in the MS and NMO were significantly higher than healthy subjects (P<0.001 for both). Also the mean of serum level of IL-17 in the MS was significantly higher than NMO (P=0.01). A positive significant correlation between age and serum level of IL-6 in all subjects (r=0.23, P=0.01). There was a positive significant correlation between age and serum level of IL-17 in MS and NMO patients (r=0.28, P=0.012).
Conclusion:
Using IL-17 and IL-6 were inflammatory markers to diagnosis of NMO, MS and healthy subjects.
-
- Similar Topics
- Replies
- Views
- Last post
-
-
Micro-RNA-96 and interleukin-10 biomarkers
by frodo » Fri Jun 21, 2019 10:54 pm » in General Discussion - 0 Replies
- 295 Views
-
Last post by frodo
Fri Jun 21, 2019 10:54 pm
-
-
- 3 Replies
- 715 Views
-
Last post by tzootsi
Sat Feb 08, 2020 6:44 am
-
- 0 Replies
- 280 Views
-
Last post by Petr75
Fri Nov 29, 2019 10:27 am
-
- 0 Replies
- 224 Views
-
Last post by frodo
Mon May 11, 2020 3:44 am
-
- 0 Replies
- 244 Views
-
Last post by frodo
Tue Sep 22, 2020 11:21 am
-
- 0 Replies
- 268 Views
-
Last post by Petr75
Sun Sep 20, 2020 1:26 am
-
- 0 Replies
- 257 Views
-
Last post by frodo
Wed Aug 12, 2020 11:14 am
-
-
Biomarkers: Status at the end of 2019
by frodo » Fri Dec 27, 2019 11:53 am » in MS Etiology and Pathogenesis - 0 Replies
- 596 Views
-
Last post by frodo
Fri Dec 27, 2019 11:53 am
-
-
-
Review about proteomics for MS biomarkers
by frodo » Tue May 28, 2019 6:24 am » in MS Etiology and Pathogenesis - 0 Replies
- 509 Views
-
Last post by frodo
Tue May 28, 2019 6:24 am
-